UK govt plans wider Rxing rights
New proposals by the UK government to make prescription medicationsmore easily available include permitting pharmacists to write repeat prescriptions, Secretary of State for Health Alan Milburn has announced.
The proposals are contained within the Health and Social Care Bill, which had its second reading in the House of Commons last week. They seek to increase the categories of health care professionals who are permitted to prescribe; currently, only doctors, dentists and, to a limited degree, community nurses, can do so. Such a development would require the setting-up of an advisory body to make recommendations on which groups should be able to prescribe what products, and under which circumstances.
Mr Milburn has also announced plans to increase the availability of drugs for stomach cancer patients, as part of a L100 million ($149.5 million) investment in improving the treatment of cancer and heart disease.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze